6-Bromo-4-fluoro-1H-indazol-3-amine
97%
- Product Code: 148777
CAS:
1227912-19-7
| Molecular Weight: | 230.04 g./mol | Molecular Formula: | C₇H₅BrFN₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD24368896 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry and sealed from light |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification, making it valuable in medicinal chemistry for designing drugs targeting specific signaling pathways. Commonly employed in research settings to develop potential therapeutics for oncology and inflammatory diseases due to its ability to enhance binding affinity and metabolic stability in lead compounds.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 250mg | 10-20 days | ฿1,460.00 |
+
-
|
| 1g | 10-20 days | ฿5,120.00 |
+
-
|
| 5g | 10-20 days | ฿24,520.00 |
+
-
|
6-Bromo-4-fluoro-1H-indazol-3-amine
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification, making it valuable in medicinal chemistry for designing drugs targeting specific signaling pathways. Commonly employed in research settings to develop potential therapeutics for oncology and inflammatory diseases due to its ability to enhance binding affinity and metabolic stability in lead compounds.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :